Monoclonal Antibody Shows Protection Against Malaria
But is intravenous administration going to get in the way?
Stay updated with breaking news from Immunity Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
But is intravenous administration going to get in the way?
One dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa, a National Institutes of Health clinical trial has found.
In a clinical trial, a monoclonal antibody safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa.
One dose of a new monoclonal antibody discovered and developed at the National Institutes of Health safely prevented malaria for up to nine months in people who were exposed to the malaria parasite.
NIH scientists identify nutrient that helps prevent bacterial infection Klebsiella pneumoniae ( Kpn). The finding, published in the journal Cell by scientists from five institutes of the National Institutes of Health, could aid efforts seeking alternatives to antibiotics. Scientists know that microbiota — the trillions of beneficial microbes living harmoniously inside our gut — can protect people from bacterial infections, but little is known about how they provide protection. Scientists are studying the microbiota with an eye to finding or enhancing natural treatments to replace anti...